This announcement is a separate document:
上海医药集团股份有限公司关于氯沙坦钾氢氯噻嗪片通过仿制药一致性评价的公告
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on losartan potassium hydrochlorothiazide tablets passing the generic drug consistency evaluation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated